Laboratorios Farmaceutico... (LABFF)
PNK: LABFF
· Real-Time Price · USD
90.61
0.00 (0.00%)
At close: Apr 30, 2025, 8:00 PM
0.00% (1D)
| Bid | 90.61 |
| Market Cap | 4.63B |
| Revenue (ttm) | 999.02M |
| Net Income (ttm) | 206.03M |
| EPS (ttm) | 3.13 |
| PE Ratio (ttm) | 28.95 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 90.61 |
| Volume | 100 |
| Avg. Volume (20D) | 25.381 |
| Open | 90.61 |
| Previous Close | 90.61 |
| Day's Range | 90.61 - 90.61 |
| 52-Week Range | 86.05 - 90.61 |
| Beta | 0.47 |
About LABFF
Laboratorios Farmaceuticos Rovi, S.A. engages in the research, development, production, and sale of pharmaceutical products in Spain, European Union, OECD countries, and internationally. The company distributes other products that are licensed from other laboratories. Its principal products include Hibor, a low-molecular-weight heparin to prevent and treat venous thromboembolic disease; Enoxaparin biosimilar Becat, a low-molecular-weight heparin;...
Industry Biotechnology
Sector Healthcare
IPO Date Apr 5, 2021
Employees 2,197
Stock Exchange PNK
Ticker Symbol LABFF
Website https://www.rovi.es
